GlassScriptPhysician profile
Susan L Ryan
NPI 1780633719
$1,248.34
in general payments reported to CMS, 2019-2025
21 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $178 · 2021: $18.25 · 2022: $227 · 2023: $124 · 2024: $158 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $284.91 | 2019-2025 | Dyanavel Xr |
| Kaleo, INC. | $146.21 | 2019-2023 | Auvi-Q |
| Corium, LLC | $143.76 | 2022-2024 | Azstarys |
| Pfizer INC. | $130.34 | 2019-2023 | |
| Glaxosmithkline, LLC. | $94.77 | 2019-2024 | Bexsero, Menveo |
| Cranial Technologies, INC | $78.66 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $73.38 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $65.31 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $28.11 | 2022-2023 | |
| Noven Therapeutics, LLC | $22.36 | 2024 | Xelstrym |
| Takeda Pharmaceuticals U.S.A., INC. | $21.81 | 2020 | |
| Axonics, INC. | $19.59 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.72 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $18.17 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.73 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $15.58 | 2025 | Neffy |
| Vertical Pharmaceuticals, LLC | $15.41 | 2024 | Relexxii |
| Kowa Pharmaceuticals America, INC. | $14.30 | 2025 | Zoryve |
| Phadia US INC. | $14.00 | 2024 | Immunocap |
| Novartis Pharmaceuticals Corporation | $13.44 | 2019 | |
| Galderma Laboratories, L.P. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.